By David McKeon -
For the first time, NYSCF scientists generated induced pluripotent stem (iPS) cells lines from skin samples of patients with primary progressive multiple sclerosis and further, they developed an accelerated protocol to induce these stem cells into becoming oligodendrocytes, the myelin-forming cells of the central nervous system implicated in multiple sclerosis and many other diseases.
READ MORE ON THE NEW YORK STEM CELL FOUNDATION
A cure for multiple sclerosis is getting closer using induced pluripotent stem cells from patients
